SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on health security. Its primary product is TPOXX (tecovirimat), an antiviral treatment for smallpox and related orthopoxvirus diseases. SIGA supplies TPOXX to the U.S. government under the BARDA Contract with the Biomedical Advanced Research and Development Authority, and also markets TPOXX internationally in the nascent biodefense market.
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001437749-26-007557 | EDGAR | 51K words |
| 2025-03-11 | 2024-12-31 | 0001437749-25-007056 | EDGAR | — |
| 2024-03-12 | 2023-12-31 | 0001437749-24-007487 | EDGAR | — |
| 2023-03-02 | 2022-12-31 | 0001437749-23-005241 | EDGAR | — |
| 2022-03-03 | 2021-12-31 | 0001437749-22-005179 | EDGAR | — |
| 2021-03-04 | 2020-12-31 | 0001437749-21-005031 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0001010086-20-000006 | EDGAR | — |
| 2019-03-06 | 2018-12-31 | 0001010086-19-000007 | EDGAR | — |
| 2018-03-06 | 2017-12-31 | 0001010086-18-000003 | EDGAR | — |
| 2017-03-07 | 2016-12-31 | 0001010086-17-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001437749-25-033636 | EDGAR | 17K words |
| 2025-08-05 | 2025-06-30 | 0001437749-25-024889 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001437749-25-015542 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001437749-24-033966 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001437749-24-024320 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001437749-24-015124 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030675 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001437749-23-022546 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001437749-23-012593 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001437749-22-025799 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001437749-22-018940 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001437749-22-011147 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001140361-26-011361 | EDGAR | 0K words |
| 2026-03-10 | 0001140361-26-008782 | EDGAR | — |
| 2025-11-06 | 0001140361-25-040775 | EDGAR | — |
| 2025-08-05 | 0001140361-25-028821 | EDGAR | — |
| 2025-06-12 | 0001140361-25-022316 | EDGAR | — |
| 2025-05-08 | 0001140361-25-017954 | EDGAR | — |
| 2025-04-08 | 0001140361-25-012708 | EDGAR | — |
| 2025-03-18 | 0001140361-25-009163 | EDGAR | — |
| 2025-03-11 | 0001140361-25-008092 | EDGAR | — |
| 2024-12-13 | 0001140361-24-049534 | EDGAR | — |
350 total filings indexed. 318 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001010086 |
| Ticker | SIGA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.siga.com |
| Listed | 1997-09-09 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report